Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Sam Citron who wrote (7591)	12/22/2002 2:23:09 PM
From: scaram(o)uche	Respond to of 52153

>> Why should we lock the courtroom door on this particular class of plaintiffs when we have not done so for so many other putative classes of injured parties? << Why should we be stoooooopid, going forward, when we've been stooooooopid, in the past? Because, at some point, sane minds must prevail over those of the ambulance chasers. Or we can keep the large price premium that is built into medicines, that which is EXPECTED to be shared with trial lawyers. Message 18272348 The system is perfect, as is, for attorneys. No? "Keep pharmaceuticals at those absurd margins, so we can get our share. In the name of those poor, Injured Parties, of course!!!!!!" Pharmaceuticals create wealth for (1) company executives and management, (2) trial lawyers, and (3) those Injured Parties of yours. They create poverty for many of those who simply need effective medicines. You want a field day for attorneys? Get rid of FDA. Otherwise, let's cut down on the cost of medicines. We can start by eliminating the ambulance chasers.